Ketorolac vs Oxycodone for Great Toe Arthrodesis

Purpose

This study reviews if taking ketorolac, after a joint fusion procedure, can decrease the need for taking oxycodone (standard of care) for pain relief. The study also investigates if ketorolac affects bone healing after surgery.

Condition

  • Arthrodesis

Eligibility

Eligible Ages
Between 18 Years and 75 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age 18 - 75 years. - Women of childbearing potential must have a negative serum or urine pregnancy test results within 24 hours before the first dose of ketorolac. - Primary elective great toe MTP arthrodesis (CPT 28750). Other forefoot procedures often performed in conjunction with toe fusion will be included (CPT codes 28308, 28285, 28270).

Exclusion Criteria

  • Chronic pain syndrome, CRPS or fibromyalgia - Revision procedures - Use of allograft bone at the fusion site - Tobacco use - Diabetes - Narcotic abuse or IV drug abuse - Any CPT codes involving the midfoot, hindfoot, and/or ankle - Unable to take NSAIDs secondary to medical comorbidities such as kidney disease (impaired renal function with CrCl ≤ 50 ml/min) or gastric ulcers - Weight < 50 kg - Does not speak or read English - If pregnant or planning to become pregnant or breastfeeding - Non-independent dweller (prisoner)

Study Design

Phase
Phase 1
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Group 1 (Control group) - Oxycodone only
Subjects randomized to this group will receive oxycodone for postop pain management (standard of care).
  • Drug: Oxycodone
    Subjects randomized to the control group will receive oxycodone for postop pain management (standard of care).
Experimental
Group 2 (Treatment group) - Oxycodone and Ketorolac
Subjects randomized to this group will receive oxycodone and ketorolac for postop pain management.
  • Drug: Oxycodone
    Subjects randomized to the control group will receive oxycodone for postop pain management (standard of care).
  • Drug: Ketorolac
    Subjects randomized to the treatment group will receive oxycodone and ketorolac for postop pain management.

Recruiting Locations

Amy Loveland
Baltimore, Maryland 21218
Contact:
Amy Loveland
301-560-2937
amy.loveland@medstar.net

More Details

Status
Recruiting
Sponsor
Medstar Health Research Institute

Study Contact

Amy Loveland
3015602937
amy.loveland@medstar.net

Detailed Description

This study reviews if taking ketorolac, after a joint fusion procedure, can decrease the need for taking oxycodone (standard of care) for pain relief. The study also investigates if ketorolac affects bone healing after surgery.